Also on August 1, 2023, Matthew T. Moroun sold 3,200,000 shares of Common Stock of the Company to the Swiftsure Trust, for which he serves as trustee and Frederick P. Calderone serves as special trustee. The source of funds for the purchase by the Swiftsure Trust was an interest-bearing note to Matthew T. Moroun. The purchase price was $78,769,000 based on the number of shares multiplied by a per share price of $24.6153. The parties agreed to use the same per share price as determined by an independent third party for the above transaction involving the 2020 Lindsay Moroun Trust.
Item 4. Purpose of Transaction
Item 4 of the Schedule 13D is hereby amended and supplemented by inserting the following paragraphs after the thirteenth paragraph thereof:
Since the filing of Amendment No. 10 on May 16, 2023, the appointment of Frederick P. Calderone as special trustee of the 2020 Lindsay Moroun Trust, the 2020 Nora Moroun Trust, the Swiftsure Trust and the 2020 AAM Trust and the transactions set forth in Item 3 (i) increased the aggregate shares of Common Stock beneficially owned by the 2020 Lindsay Moroun Trust from 762,042 shares (2.9% of the Company’s outstanding shares of Common Stock on May 11, 2023) to 11,866,015 shares (45.1% of the Company’s outstanding shares of Common Stock on May 11, 2023); (ii) resulted in the Swiftsure Trust, which did not previously own any shares of Common Stock, becoming the beneficial owner of 3,200,000 shares (12.2% of the Company’s outstanding shares of Common Stock on May 11, 2023); and (iii) increased the aggregate shares of Common Stock beneficially owned by Frederick P. Calderone from 590 shares, held directly in his individual capacity, to 18,962,534 shares (72.1% of the Company’s outstanding shares of Common Stock on May 11, 2023), including 18,961,944 held by the 2020 Lindsay Moroun Trust, the 2020 Nora Moroun Trust, the Swiftsure Trust, and the 2020 AAM Trust, for each of which he serves as special trustee. The transactions set forth in Item 3 were effected for ownership succession purposes.
The final three paragraphs of Item 4 of the Schedule 13D are hereby amended and restated in their entirety to read as follows:
The Reporting Persons may, from time to time, acquire additional shares of the Company’s Common Stock or dispose of shares of the Company’s Common Stock including, without limitation, distributing some or all of such shares to such Reporting Person’s beneficiaries or transferees. The Reporting Persons may also make other transfers of the Company’s Common Stock, depending upon each such Reporting Person’s ongoing evaluation of his, her or its investment in the Company’s Common Stock, applicable legal restrictions, prevailing market conditions, other investment opportunities, liquidity requirements of such Reporting Person, subsequent developments affecting the Company, the Company’s business and prospects, tax considerations, general stock market and economic conditions or other investment considerations.
In Matthew T. Moroun’s capacity as Chairman of the board of directors of the Company and in Frederick P. Calderone’s capacity as a member of the board of directors of the Company, each may take an active role in working with the Company’s management on operational, financial and strategic initiatives. In addition, each Reporting Person, in his, her or its capacity as a shareholder of the Company, may engage in communications with one or more of the Company’s other shareholders, officers, directors or representatives regarding the Company. Each of the Reporting Persons, in his, her or its capacity as a shareholder of the Company, may discuss ideas that, if effected may relate to, or may result in, any of the matters listed in Items 4(a)-(j) of Schedule 13D.
Other than as described above, each of the Reporting Persons reports that he, she or it currently does not have any specific plan or proposal which relates to, or may result in, any of the matters listed in Items 4(a)-(j) of Schedule 13D.
Item 5. Interest in Securities of the Issuer
Paragraphs (a), (c) and (d) of Item 5 of the Schedule 13D are hereby amended and restated in their entirety to read as follows:
| (a) | The aggregate number and percentage of the class of securities identified pursuant to Item 1 beneficially owned by each Reporting Person are stated in Items 11 and 13 on the cover page for each such Reporting Person. The percentage of shares of Common Stock beneficially owned by each Reporting Person is based on 26,287,973 shares of Common Stock outstanding as of May 8, 2023, as disclosed in the Company’s most recent Form 10-Q filed on May 11, 2023. |
| (c) | Except for the transactions described in this Amendment No. 11, the Reporting Persons have not engaged in any transactions in the Common Stock during the past sixty days. |
| (d) | Matthew T. Moroun’s wife, Lindsay S. Moroun, and son, Matthew J. Moroun, each has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, shares held by each of them (285,550 shares held by Lindsay S. Moroun and 1,237 shares held by Matthew J. Moroun) which are reported as beneficially owned by Matthew T. Moroun. Neither the filing of this report nor any of its contents shall be deemed an admission that Matthew T. Moroun is |
Page 9 of 11